Skip to search.
 FTSE 100 Down 2.71%

Horizon Pharma plc (HZNP)

-NasdaqGS
16.07 Down 1.08(6.30%) 8 Feb 21:00
|After Hours: : 15.98 Down 0.09 (0.56%) 8 Feb 23:36
Prev Close:17.15
Open:16.80
Bid:15.76 x 700
Ask:18.50 x 100
1y Target Est:36.55
Beta:1.74895
Next Earnings Date:29-Feb-16HZNP Earnings announcement
Day's Range:15.54 - 16.89
52wk Range:12.86 - 39.49
Volume:4,027,787
Avg Vol (3m):5,022,930
Market Cap:2.56b
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HZNPDown 6.30%2.56b
POZN 0.00%194.63m
ABTUp 0.13%55.88b
PFEDown 1.62%176.32b

Key Statistics

Forward P/E (1 yr):6.61
P/S (ttm):4.43
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :1.94
Quarterly EPS Est (Dec-15) :0.62
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback